Related Experiment Video
Updated: Jan 23, 2026

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors
Published on: June 27, 2025
Plasminogen activator/plasminogen activator inhibitors in ovarian physiology
1State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100080, China. liuyx@ioz.ac.cn
Abstract:
The target extracellular matrix (ECM) degradation generated by plasminogen activator (PA) and regulated by plasminogen activator inhibitor (PAI) is an event that affects a wide variety of physiological and pathological processes in the ovary. Studies carried out over the past 25 years in a number of laboratories have elucidated some of the biochemical events related to the function and regulation of the PA system in the ovary. Hormone-induced coordinated expression of tissue-type PA (tPA) produced mainly by granulosa cells and its inhibitor PAI-1 secreted by theca cells in the preovulatory follicles is responsible for a controlled and directed proteolysis leading to the rupture of selected follicles in the rat, monkey and other mammals. Increase in tPA and PAI-1 expression in corpus luteum (CL) of rat and monkey at a later stage is well correlated with a sharp decrease in CL progesterone production, indicating its important role in the initiation of luteal regression. In contrast, the urokinase-type PA (uPA) may play an essential role in the early growing follicles during cell proliferation and migration, and in the early CL formation related to ECM degradation and angiogenesis. Ovarian function is also modulated by endogenously-produced local factors that regulate expression of the PA activator and inhibitor, and the MMP system. Thus, the next challenge is to identify the interrelationship between multiple paracrine and autocrine factors and the PA system, and to know how they regulate the protease and the protease inhibitor in the ovary.
Insights
The ovarian plasminogen activator (PA) system, regulated by plasminogen activator inhibitor (PAI), is crucial for ovulation and luteal regression. Understanding its interaction with local factors is key to ovarian function research.
Area of Science:
- Reproductive biology
- Molecular endocrinology
- Extracellular matrix biology
Background:
- The plasminogen activator (PA) system, involving activators (PA) and inhibitors (PAI), regulates extracellular matrix (ECM) degradation, a vital process in ovarian physiology.
- Previous research has identified the roles of tissue-type PA (tPA) and urokinase-type PA (uPA), along with PAI-1, in specific ovarian events.
Purpose of the Study:
- To elucidate the function and regulation of the PA system in the ovary.
- To investigate the roles of tPA and uPA in follicular development, ovulation, and corpus luteum (CL) formation and regression.
- To explore the interplay between the PA system and other local factors modulating ovarian function.
Main Methods:
- Review of studies over the past 25 years on PA system function and regulation in the ovary.
- Analysis of hormonal regulation of tPA and PAI-1 expression in preovulatory follicles.
- Correlation of tPA and PAI-1 expression in the CL with progesterone production and luteal regression.
- Examination of uPA's role in early follicular growth, CL formation, ECM degradation, and angiogenesis.
Main Results:
- Hormone-induced tPA and PAI-1 expression in preovulatory follicles drives controlled proteolysis for follicle rupture.
- Increased tPA and PAI-1 in the CL correlates with decreased progesterone and initiates luteal regression.
- uPA is implicated in early follicular growth, cell proliferation, migration, ECM degradation, and angiogenesis during early CL formation.
Conclusions:
- The PA system plays distinct roles in various ovarian processes, from follicular development to luteal regression.
- Coordinated expression of tPA and PAI-1 is essential for ovulation and luteal regression.
- uPA contributes to early follicular and CL development through ECM remodeling and angiogenesis.
- Future research should focus on the complex interactions between the PA system and local paracrine/autocrine factors in the ovary.
Related Concept Videos
Co-activators and Co-repressors
tRNA Activation
tRNA Activation
Activation Energy
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

